Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-19

Clinical Trial Update: An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

View source ↗

Summary

An observational study of patients treated with bimatoprost 0.03% (Latisse) for hypotrichosis of the eyelashes has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LATISSE (BIMATOPROST)

Snippet

Sponsor: Allergan | Conditions: Eyelash Hypotrichosis | Status: COMPLETED | Results posted: 2012-09-19